BIODESIX INC (BDSX:NASDAQ)
$21.26 0.08 (0.3777%)
Analysed BIODESIX INC (BDSX:NASDAQ) News Sources
What Makes Biodesix, Inc. (BDSX) a Strong Momentum Stock: Buy Now?
31-08-2026
yahoo.com
Biodesix to Participate in Upcoming Investor Conferences
03-09-2026
yahoo.com
Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring
24-09-2026
yahoo.com
Biodesix Advances MRD Monitoring Programs With Bio-Rad and Thermo Fisher
24-09-2026
advfn.com
Biodesix Expands MRD Testing With Tumor-Informed and Tumor-Naive Tests
28-09-2026
yahoo.com
Biodesix to Present New Real-World Evidence Supporting Integration of Nodify Lung® Testing into Routine Lung Nodule Care at CHEST 2026
13-10-2026
yahoo.com
Biodesix (BDSX) Stock Sees Fair Value Lift As Analysts Back MRD Growth
15-10-2026
yahoo.com
Biodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging Biomarkers
19-10-2026
yahoo.com
American College of Chest Physicians Publishes New Framework for Lung Nodule Programs Recommending Biomarkers for Risk Stratification
19-10-2026
yahoo.com
Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026
22-10-2026
yahoo.com
What is the current price of BIODESIX INC (BDSX:NASDAQ)?
The current price of BIODESIX INC (BDSX:NASDAQ) is $21.26.
BIODESIX INC (BDSX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIODESIX INC (BDSX:NASDAQ) since the previous trading day is $0.08.
BIODESIX INC (BDSX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIODESIX INC (BDSX:NASDAQ) since the previous trading day is 0.3777%.
What is the most recent average sentiment score for BIODESIX INC (BDSX:NASDAQ)?
The most recent average sentiment score for BIODESIX INC (BDSX:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for BIODESIX INC (BDSX:NASDAQ)?
The most recent sentiment for BIODESIX INC (BDSX:NASDAQ) is .
SEC-8K** Filing Available For BIODESIX INC (BDSX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.